TY - JOUR
T1 - Analysis of native proteins from biological fluids by biomolecular interaction analysis mass spectrometry (BIA/MS)
T2 - Exploring the limit of detection, identification of non-specific binding and detection of multi-protein complexes
AU - Nedelkov, Dobrin
AU - Nelson, Randall W.
N1 - Funding Information:
This publication was supported in part by grant number 1 R43 CA82079-01 from the National Cancer Institute. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.
PY - 2001
Y1 - 2001
N2 - Biomolecular interaction analysis mass spectrometry (BIA/MS) is a two-dimensional analytical technique that quantitatively and qualitatively detects analytes of interests. In the first dimension, surface plasmon resonance (SPR) is utilized for detection of biomolecules in their native environment. Because SPR detection is non-destructive, analyte(s) retained on the SPR-active sensor surface can be analyzed in a second dimension using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. The qualitative nature of the MALDI-TOF MS analysis complements the quantitative character of SPR sensing and overcomes the shortcomings of the SPR detection stemming from the inability to differentiate and characterize multi-protein complexes and non-specific binding. In this work, the benefit of performing MS analysis following SPR sensing is established. Retrieval and detection of four markers present in biological fluids (cystatin C, beta-2-microglobulin, urinary protein 1 and retinol binding protein) was explored to demonstrate the effectiveness of BIA/MS in simultaneous detection of clinically related biomarkers and delineation of non-specific binding. Furthermore, the BIA/MS limit of detection at very low SPR responses was investigated. Finally, detection of in-vivo assembled protein complexes was achieved for the first time using BIA/MS.
AB - Biomolecular interaction analysis mass spectrometry (BIA/MS) is a two-dimensional analytical technique that quantitatively and qualitatively detects analytes of interests. In the first dimension, surface plasmon resonance (SPR) is utilized for detection of biomolecules in their native environment. Because SPR detection is non-destructive, analyte(s) retained on the SPR-active sensor surface can be analyzed in a second dimension using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. The qualitative nature of the MALDI-TOF MS analysis complements the quantitative character of SPR sensing and overcomes the shortcomings of the SPR detection stemming from the inability to differentiate and characterize multi-protein complexes and non-specific binding. In this work, the benefit of performing MS analysis following SPR sensing is established. Retrieval and detection of four markers present in biological fluids (cystatin C, beta-2-microglobulin, urinary protein 1 and retinol binding protein) was explored to demonstrate the effectiveness of BIA/MS in simultaneous detection of clinically related biomarkers and delineation of non-specific binding. Furthermore, the BIA/MS limit of detection at very low SPR responses was investigated. Finally, detection of in-vivo assembled protein complexes was achieved for the first time using BIA/MS.
KW - BIA/MS
KW - Limit of detection
KW - MALDI-TOF mass spectrometry
KW - Non-specific binding
KW - Protein complexes
KW - SPR
UR - http://www.scopus.com/inward/record.url?scp=0034775618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034775618&partnerID=8YFLogxK
U2 - 10.1016/S0956-5663(01)00229-9
DO - 10.1016/S0956-5663(01)00229-9
M3 - Article
C2 - 11679291
AN - SCOPUS:0034775618
SN - 0956-5663
VL - 16
SP - 1071
EP - 1078
JO - Biosensors and Bioelectronics
JF - Biosensors and Bioelectronics
IS - 9-12
ER -